Including marginalized populations in HIV clinical trials: a new role for nurse-researchers.
This article proposes a new paradigm for nurse-researchers to strengthen communication with participants, investigators, and the community in clinical trials. The author reviews the current state of HIV vaccine development in response to the human and fiscal cost of the HIV epidemic, both in the United States and globally. A translational model is proposed for restructuring the process by which participants in HIV trials are recruited and the results disseminated. Finally, it is proposed that nurses should play a unique and essential role in implementing this new model, advocating for individuals, strengthening societal trust, and fostering equity.
Cohn
Elizabeth Gross
EG
Adelphi University, Alumnae Hall, 1 South Avenue, Garden City, NY 11530, USA. cohn@adelphi.edu
D016915:AIDS Vaccines; D015400:Clinical Nursing Research / Q000458:organization & administration*; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008913:Minority Groups; D016294:Models, Nursing; D018579:Patient Selection
D016915:AIDS Vaccines